Perfil
Benjamin Perry is the founder of MPC Therapeutics SA, holding the title of Director since 2018.
Dr. Perry is a Venture Partner at Medicxi Ventures (Jersey) Ltd. since 2022.
Education includes a doctorate from Imperial College London, conferred in 2002, and a graduate degree from Swansea University, conferred in 1999.
Cargos activos de Benjamin Perry
| Empresas | Cargo | Inicio |
|---|---|---|
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi invests in biopharma companies located in Europe. The firm provides financing for early and late stage capital requirements. | Inversor de Capital Privado | 01/11/2022 |
MPC Therapeutics SA
MPC Therapeutics SA BiotechnologyHealth Technology Develops small molecules which modulate mitochondrial functions | Fundador | 01/01/2018 |
Formación de Benjamin Perry.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swansea University
Swansea University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi invests in biopharma companies located in Europe. The firm provides financing for early and late stage capital requirements. | Finance |
MPC Therapeutics SA
MPC Therapeutics SA BiotechnologyHealth Technology Develops small molecules which modulate mitochondrial functions | Health Technology |
- Bolsa de valores
- Insiders
- Benjamin Perry
















